Evonik Industries (EVK) Given a €27.00 Price Target at UBS
Evonik Industries (FRA:EVK) has been assigned a €27.00 ($32.14) price objective by equities researchers at UBS in a research note issued to investors on Thursday, www.boersen-zeitung.de reports. The brokerage currently has a “sell” rating on the stock. UBS’s price objective suggests a potential downside of 15.97% from the stock’s current price.
A number of other research firms have also commented on EVK. Deutsche Bank set a €40.00 ($47.62) price objective on shares of Evonik Industries and gave the company a “buy” rating in a research note on Monday. Goldman Sachs Group set a €29.00 ($34.52) target price on Evonik Industries and gave the company a “neutral” rating in a report on Wednesday, October 11th. Nord/LB set a €31.00 ($36.90) target price on Evonik Industries and gave the company a “neutral” rating in a report on Friday, November 3rd. DZ Bank restated a “neutral” rating on shares of Evonik Industries in a report on Friday, November 3rd. Finally, Kepler Capital Markets set a €31.00 ($36.90) price objective on Evonik Industries and gave the stock a “neutral” rating in a report on Thursday, October 5th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and eleven have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of €33.75 ($40.18).
Shares of Evonik Industries (FRA:EVK) opened at €32.13 ($38.25) on Thursday. Evonik Industries has a 1-year low of €25.74 ($30.64) and a 1-year high of €32.97 ($39.25).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries AG and related companies with MarketBeat.com's FREE daily email newsletter.